Recent Updates
Recently added Catalysts
HCM Positive Sentiment Score: 60/100

Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ - Wednesday

Key Takeaway: HUTCHMED (China) Limited announced that as of May 31, 2023, its issued share capital consists of 866,161,450 ordinary shares, all of which carry voting rights. This figure will assist shareholders in determining if they need to disclose any interest changes under market regulations. The announcement also outlines the equivalency of ordinary shares to depositary interests and American depositary shares traded on respective stock exchanges.

Market Sentiment Analysis

POSITIVE FACTORS

  • HUTCHMED has a significant number of issued shares, indicating investor interest.
  • The transparency regarding shareholder notification is emphasized.
  • Shareholders are provided with equivalent options in trading formats.

Full Press Release Details

Hong Kong, Shanghai, & Florham Park, NJ - Wednesday, May 31, 2023: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; HKEX: 13) hereby notifies the market that as at May 31, 2023, the issued share capital of HUTCHMED consisted of 866,161,450 ordinary shares of US$0.10 each, with each share carrying one right to vote and with no shares held in treasury.
The above figure of 866,161,450 may be used by shareholders as the denominator for the calculations by which they could determine if they are required to notify their interest in, or a change to their interest in, HUTCHMED under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
For illustrative purposes only, the 866,161,450 ordinary shares would be equivalent to 866,161,450 depositary interests (each equating to one ordinary share) which are traded on AIM or, if the depositary interests were converted in their entirety, equivalent to 173,232,290 American depositary shares (each equating to five ordinary shares) which are traded on Nasdaq.
Investor Enquiries
Mark Lee, Senior Vice President +852 2121 8200
Annie Cheng, Vice President +1 (973) 306 4490
Media Enquiries
Americas - Brad Miles, Solebury Strategic Communications +1 (917) 570 7340 (Mobile) / bmiles@soleburystrat.com
Europe - Ben Atwell / Alex Shaw, FTI Consulting +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile) HUTCHMED@fticonsulting.com
Asia - Zhou Yi, Brunswick +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Nominated Advisor
Atholl Tweedie / Freddy Crossley / Daphne Zhang, Panmure Gordon +44 (20) 7886 2500

Frequently Asked Questions

What is HUTCHMED's issued share capital as of May 31, 2023?

HUTCHMED's issued share capital is 866,161,450 ordinary shares.

Do HUTCHMED shares carry voting rights?

Yes, each share carries one voting right.

How many American depositary shares equal HUTCHMED's ordinary shares?

HUTCHMED's 866,161,450 shares equate to 173,232,290 American depositary shares.

Who can be contacted for investor inquiries at HUTCHMED?

Mark Lee and Annie Cheng are available for investor inquiries.

Where can I find media contact details for HUTCHMED?

Media contact details are provided for Americas, Europe, and Asia.

Last updated: May 31, 2023